The World Health Organization (WHO) is convening a panel of experts today to discuss potential vaccine options for a major Ebola outbreak in the eastern Democratic Republic of Congo (DRC). The outbreak involves the Bundibugyo strain of Ebola, which has resulted in 131 suspected deaths and 500 reported cases. Both the WHO and the Africa Centers for Disease Control and Prevention have declared the situation a public health emergency.
No Approved Vaccines for Bundibugyo Strain
Currently, there are no approved vaccines or treatments specifically designed for the Bundibugyo strain, which has a fatality rate of up to 40 per cent. The expert panel will consider several options, including the Ervebo vaccine, which is approved for the Ebola Zaire strain. Ervebo has demonstrated some protective effects against Bundibugyo in animal studies.
WHO Mobilises Supplies
In response to the outbreak, WHO workers have mobilised 4.7 tonnes of essential medical supplies and emergency kits to support affected regions. These supplies are critical for containing the spread of the virus and providing care to those infected.
The meeting of experts underscores the urgency of finding effective countermeasures against this deadly pathogen. The outbreak has raised concerns across Africa and the global health community, prompting swift action from international health organisations.
